Dialybrid raises €15 million to test a silk-based graft

Tech Funding News reports that XGEN Venture led the Series A, with participation from CDP Venture Capital SGR’s Rilancio Fund.

1 Source, 19d ago, first seen 19d ago

TLDR

Dialybrid has raised €15 million to test a graft woven from silk, Tech Funding News reports. New investor XGEN Venture led the Series A, joined by CDP Venture Capital SGR’s Rilancio Fund. XGEN is an Italian life sciences fund that closed at €180 million in December 2024.

Today's Rank

—

Not ranked yet

Combined views

112

1 Source, first seen 19d ago

1 likes

Sentiment

Positive——Negative

Summary

Not enough discussion yet.

No sentiment analysis available yet.

Featured Source